(SOURCE: MCGILL UNIVERSITY) – Ocrelizumab shown to reduce new attacks/symptom progression in some patients. In separate clinical trials, a drug called ocrelizumab has been shown to reduce new attacks in patients with relapsing remitting multiple sclerosis (MS), and new symptom progression in primary progressive MS. Three studies conducted by an international team of researchers, which included […]
(SOURCE: UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT HOUSTON) – Positive results of an investigational medication study for primary progressive multiple sclerosis were published online in today’s New England Journal of Medicine in a paper led by senior author Jerry Wolinsky, M.D., of McGovern Medical School at The University of Texas Health Science Center at Houston (UTHealth). […]
(SOURCE: TECHNICAL UNIVERSITY OF MUNICH) – T cells are an important part of the immune system. However, they are not only capable of destroying pathogens. They can also become harmful themselves. Researchers at the Technical University of Munich (TUM) and the University Medical Center of the Johannes Gutenberg University Mainz have discovered the conditions under […]
(Medical News Today) According to a recent article published in Medical News Today, most people with Multiple Sclerosis are initially diagnosed with relapsing-remitting MS (RRMS). In RRMS, there are clear episodes of inflammatory activity (relapses). During a relapse, there are new or worsening symptoms. Relapses are also called attacks, flare-ups, or exacerbations. People with RRMS […]
(Multiple Sclerosis News Today) According to a recent article published in Multiple Sclerosis Today, therapies which are aimed at regenerating the myelin sheath can work to restore proper brain activity and may be a viable way of treating multiple sclerosis (MS), according to researchers at the University of California San Francisco.
(MedScape) According to a recent article published in MedScape, a possible blood test for Multiple Sclerosis (MS) is currently being studied.
(News-medical.net) According to a recent article published in news-medical.net, a new Tel Aviv University study which was published in the Journal of the American Chemical Society (JACS) located a structural instability in the myelin membranes, the “insulating tape” surrounding neurons. This vulnerability provides the immune system with access to otherwise protected regions.
(Medical Daily) According to a recent study published in Neurology, treating multiple sclerosis (MS) early may help reduce likelihood of being diagnosed with clinical MS.